| Literature DB >> 34836437 |
Anastasia Konstantina Sakali1, Alexandra Bargiota1, Ioannis G Fatouros2, Athanasios Jamurtas2, Djuro Macut3, George Mastorakos4, Maria Papagianni5,6.
Abstract
Pesticide residues are largely found in daily consumed food because of their extensive use in farming and their long half-life, which prolongs their presence in the environment. Many of these pesticides act as endocrine-disrupting chemicals after pre- or postnatal exposure, significantly affecting, among other things, the time of puberty onset, progression, and completion. In humans, precocious or delayed puberty, and early or delayed sexual maturation, may entail several negative long-term health implications. In this review, we summarize the current evidence on the impact of endocrine-disrupting pesticides upon the timing of the landmarks of female and male puberty in both animals (vaginal opening, first estrus, and balanopreputial separation) and humans (thelarche, menarche, gonadarche). Moreover, we explore the possible mechanisms of action of the reviewed endocrine-disrupting pesticides on the human reproductive system. Access to safe, healthy, and nutritious food is fundamental for the maintenance of health and wellbeing. Eliminating the presence of hazardous chemicals in largely consumed food products may increase their nutritional value and be proven beneficial for overall health. Consequently, understanding the effects of human exposure to hazardous endocrine-disrupting pesticides, and legislating against their circulation, are of major importance for the protection of health in vulnerable populations, such as children and adolescents.Entities:
Keywords: endocrine disruptors; nutrition; pesticides; puberty onset; sexual maturation
Mesh:
Substances:
Year: 2021 PMID: 34836437 PMCID: PMC8622967 DOI: 10.3390/nu13114184
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Categories of endocrine-disrupting pesticides reviewed.
| Pesticide Category | Agrochemical Substance | Metabolites |
|---|---|---|
|
| ||
|
| esfenvalerate, cypermethrin | 3-PBA |
| heptachlor, DDT (banned in EU, USA), methoxychlor (banned in USA), endosulfan (banned in EU, USA), lindane, dieldrin, endrin | DDE | |
| chlorpyrifos (banned in EU, USA) | DMP, DMTP, DMDTP, DEP, DETP, DEDTP | |
|
| atrazine (banned in EU), propazine, simazine (banned in EU), acetochlor (banned in EU), metolachlor, glyphosate | HA, DACT, DIA, DEA |
|
| prochloraz, vinclozolin (reprotoxic, banned in EU), HCB (banned in EU, USA) |
3-PBA: 3-phenoxybenzoic acid; POP: persistent organic pollutant; DDT: dichlorodiphenyltrichloroethane; EU: European Union; USA: United States of America; DDE: dichlorodiphenyldichloroethylene; DMP: dimethylphosphate; DMTP: dimethylthiophosphate; DMDTP: dimethyldithiophosphate; DEP: diethylphosphate; DETP: diethylthiophosphate; DEDTP: diethyldithiophosphate; HA: hydroxyatrazine; DACT: diaminochlorotriazine; DIA: deisopropylatrazine; DEA: deethylatrazine; HCB: hexachlorobenzene. Information on banned pesticides available at: https://pan-international.org/pan-international-consolidated-list-of-banned-pesticides (accessed on 16 November 2021).
Animal studies showing effects on puberty.
| Publications | Agrochemical Substance | Animal | Period of Exposure | Dosage | Impact on Puberty Landmarks | NOAEL for Reproductive Toxicity |
|---|---|---|---|---|---|---|
|
| ||||||
|
| ||||||
|
| ||||||
| Pine et al., 2008 [ | Esfenvalerate | Female SD rats | PND 22–VO | 0.5, 1 or 5 mg/kg/day per os | VO delay at 1 and 5 mg/kg/day | 2 mg/kg/day |
| Ye et al., 2017 [ | Cypermethrin | Male CD-1 mice | PND 7–PND 21 | 0.5, 5 or 50μg/kg/day sc | Acceleration of PPS at all dosages | 5 mg/kg/day |
|
| ||||||
| Singh et al., 2017 [ | Cypermethrin | Holtzman rats | GD 6–LCD 21 | 1, 10 or 25 mg/kg/day per os | Delay of PPS at 1 and 25 mg/kg/day | 5 mg/kg/day |
| Singh et al., 2020 [ | Cypermethrin | Holtzman rats | GD 6-LCD 21 | 1, 10 or 25 mg/kg/day per os | Delay of VO at 25 mg/kg/day | 5 mg/kg/day |
|
| ||||||
|
| ||||||
| Loeffler and Peterson 1999 [ | DDT | Holtzman rats | GD 14–GD 18 | 1, 10, 50, 100, or 200 mg/kg/day per os | PPS delay at 200 mg/kg/day | n/a |
| Maranghi et al., 2007 [ | Lindane | CD1 mice | GD 6–GD 16 | 15 mg/kg/day per os | VO acceleration | n/a |
|
| ||||||
| Rasier et al., 2007 [ | ο,p′-DDT | Female Wistar rats | PND 6–PND 10 | 10 or 100 mg/kg/day sc | VO acceleration at all dosages, acceleration of first estrus appearance at 10 mg/kg | n/a |
| Heinrichs et al., 1971 [ | ο,p′-DDT | Female SD rats | PND 2–PND 4 | 1 mg/day sc | Acceleration of VO and of first estrus appearance | n/a |
| Gellert et al., 1974 [ | ο,p′-DDT | Female SD rats | PND 2–PND 4 | 0.001, 0.01, 0.1, 0.5, or 1 mg/day sc | Dose-dependent VO acceleration at ≥0.1 mg/day | n/a |
| Ashby and Lefevre 2000 [ | DDE | Male Alderley Park rats | PND 22–55 or | 100 mg/kg/day per os | PPS delay in the PND 22–55 subgroup | n/a |
| Kelce et al., 1995 [ | Methoxychlor | Male Long–Evans rats | PND 21–PND 57 | 100 mg/kg/day per os | PPS delay | n/a |
|
| ||||||
| Martinez-Ibarra et al., 2016 [ | Heptachlor | Wistar rats | F0 generation: GD 12–LCD 21 | 4.5 mg/kg/day per os | F1 generation: VO delay | n/a |
| Smialowicz et al., 2001 [ | Heptachlor | SD rats | GD 12–LCD 7 | 0, 30, 300, or 3000 μg/kg/day per os | VO delay at 30 μg/kg/day | n/a |
| Masutomi et al., 2003 [ | Methoxychlor | SD rats | GD 15–LCD 10 | 24, 240, or 1200 ppm/day per os | VO acceleration and PPS delay at 1200 ppm | n/a |
| Roepke et al., 2016 [ | Methoxychlor | Fischer CDF rats | Mothers: GD 11–PND 0 Female offspring: PND 0–PND 7 | 75 mg/kg/day intraperitoneally to the pregnant dams, sc to the neonates | VO acceleration | n/a |
| Martini et al., 2020 [ | Methoxychlor | CD1 mice | GD 11–LCD 8 | 20 μg/kg/day per os | Acceleration of VO in female offspring, delay of PPS in male offspring | 5 mg/kg/day |
|
| ||||||
| Gray et al., 1989 [ | Methoxychlor | Male and female Long–Evans rats | PND 21–PND 80 (males) | 25, 50, 100, or 200 mg/kg/day per os | F0 generation: Acceleration of VO and of first estrus appearance at all dosages; PPS delay at 100 or 200 mg/kg/day | n/a |
| Aoyama et al., 2012 [ | Methoxychlor | Female and male SD rats | From postnatal week 5 and for 18 weeks | 10, 500, or 1500 ppm per os | PPS delay at 500 and 1500 ppm. | 10 ppm |
|
| ||||||
|
| ||||||
| Davis et al., 2011 [ | Atrazine | SD rats | GD 14–GD 21 | 1, 5, 20 or 100 mg/kg/day per os | VO delay at 100 mg/kg/day | n/a |
| Rayner et al., 2005 [ | Atrazine | Long–Evans rats | GD 13–15; GD 15–17; GD 17–19; GD 13–19 | 100 mg/kg/day per os | VO delay in the GD13–19-exposed group | n/a |
| Rayner et al., 2007 [ | Atrazine | Long–Evans rats | GD 15–GD 19 | 100 mg/kg per os | PPS delay among offspring exposed in utero and throughout lactation | n/a |
| Stanko et al., 2010 [ | Mixture of atrazine and its metabolites (HA, DACT, DIA, DEA) | Long–Evans rats | GD 15–GD 19 | 0.09, 0.87, or 8.73 mg/kg/day of the mixture or 100 mg/kg/day atrazine per os | PPS delay among offspring exposed to 0.87 or 8.73 mg/kg/day of the mixture or 100 mg/kg/day atrazine | 6.25 mg/kg/day for DACT |
| Rosenberg et al., 2008 [ | Atrazine | SD rats | GD 14–PND 0 | 1, 10, 50, 75, or 100 mg/kg/day per os | PPS delay at 50, 75, or 100 mg/kg | n/a |
|
| ||||||
| Stoker et al., 2000 [ | Atrazine | Male Wistar rats | PND 23–PND 53 | 12.5, 25, 50, 100, 150, or 200 mg/kg/day per os | PPS delay at 12.5, 50, 100, 150, or 200 mg/kg/day | 6.25 mg/kg/day |
| Stoker et al., 2002 [ | Atrazine metabolites (DEA, DIA, DACT) | Male Wistar rats | PND 23–PND 53 | 6.25, 12.5, 25, 50, 100, or 200 mg/kg/day per os in molar equivalent of atrazine | PPS delay in subgroups which received DEA or DIA (at 25, 100, and 200 mg/kg) or DACT (at ≥12.5 mg/kg) | 6.25 mg/kg/day for atrazine and DACT, 12.5 mg/kg/day for DEA and DIA |
| Ashby et al., 2002 [ | Atrazine | Female Wistar and SD rats | PND 21–PND 45 | 10, 30, or 100 mg/kg/day per os | Wistar rats: VO delay at 100 mg/kg/day | 25 mg/kg/day |
| Laws et al., 2000 [ | Atrazine | Female Wistar rats | PND 22–PND 41 | 12.5, 25, 50, 100, or 200 mg/kg per os | VO delay at 50, 100 or 200 mg/kg | 25 mg/kg/day |
| Laws et al., 2003 [ | HA or DACT (Atrazine metabolites) or Propazine | Female Wistar rats | PND 22-PND 41 | 22.8, 45.7, 91.5, or 183 mg/kg / day HA per os16.7, 33.8, 67.5, or 135 mg/kg/day DACT per os | VO delay in animals treated with ≥33.8 mg/kg DACT (dose-dependent), or with ≥106.7 mg/kg propazine | 25 mg/kg/day for atrazine, 16.7 mg/kg/day for DACT |
| Zorilla et al., 2010 [ | Simazine | Female Wistar rats | PND 22–42 or PND 22–62 | 12.5, 25, 50, 100, or 200 (not administered to the animals treated only for 21 days) mg/kg/day per os. | VO delay for the subgroups exposed at 25 and 100 mg/kg for 21 days, and the subgroups exposed to ≥25 mg/kg for 41 days. | n/a |
| Rollerova et al., 2011 [ | Acetochlor | Female Wistar rats | PND 4–PND 7 | 7.68 or 15.36 mg/kg/day sc | VO acceleration at all dosages | n/a |
| Mathias et al., 2012 [ | Metolachlor | Male Wistar rats | PND 23–PND 53 | 5 or 50 mg/kg/day per os | Dose-dependent PPS acceleration | 23.5–26 mg/kg/day |
| Romano et al., 2010 [ | Glyphosate | Male Wistar rats | PND 23–PND 53 | 5 or 50 or 250 mg/kg per os | Dose-dependent PPS delay at 50 or 250 mg/kg | 50 mg/kg/day |
|
| ||||||
| Breckenridge et al., 2015 [ | Atrazine | SD rats | F0 generation: GD 0–LCD 21 | 6.25, 25, or 50 mg/kg/day per os | VO delay at 25 or 50 mg/kg/day atrazine starting in utero, and at 50 mg/kg/day atrazine starting after weaning | 6.25 mg/kg/day |
| Manservisi et al., 2019 [ | Glyphosate-based herbicide | Female SD rats | F0 generation: GD 6–end of lactation | 175 mg/kg/day per os | Delay of first estrus appearance in F1 generation | 50 mg/kg/day |
| Romano et al., 2012 [ | Glyphosate | Wistar rats | GD 18–LCD 5 | 50 mg/kg/day per os | PPS acceleration | 50 mg/kg/day |
|
| ||||||
| McBirney et al., 2017 [ | Atrazine | Harlan SD rats | F0 generation: GD 8–GD 14 | 25 mg/kg intraperitoneally | Accelerated puberty onset in F2 generation male and F3 generation female animals | n/a |
|
| ||||||
|
| ||||||
| Blystone et al., 2007 [ | Prochloraz | Male SD rats | PND 23–PND 42; PND 23 –PND 51 | 31.3, 62.5, or 125 mg/kg/day per os | PPS delay at 125 mg/kg/day | 5 mg/kg/day |
|
| ||||||
| Schneider et al., 2017 [ | Mixture of vinclozolin/flutamide/prochloraz | Wistar rats | GD 6–LCD 21 and PND 21–puberty onset; PND 21–83 | 0.005/0.00025/0.01, 4/0.025/5 or 20/0.25/30 mg/kg/day per os | PPS delay at 20/0.25/30 mg/kg/day | 4/0.025/5 mg/kg/day |
| Melching-Kolmuss et al., 2017 [ | Prochloraz | Wistar rats | GD 6–LCD 21 | 0.01, 5, or 30 mg/kg/day per os | PPS delay at 30 mg/kg/day | 5 mg/kg/day |
NOAEL: no-observed-adverse-effect level; SD: Sprague–Dawley; PND: postnatal day; VO: vaginal opening; sc: subcutaneous; PPS: preputial separation; GD: gestation day; LCD: lactation day; DDT: dichlorodiphenyltrichloroethane; DDE: dichlorodiphenyldichloroethylene; DEA: deethylatrazine; DIA: deisopropylatrazine; DACT: diaminochlorotriazine; HA: hydroxyatrazine.
Reviewed human studies.
| Publications | Agrochemical Substance | Sex, Number ( | Age (Years) | Biological Matrice /Method | Impact on Puberty Landmarks |
|---|---|---|---|---|---|
|
| |||||
|
| |||||
| Ye et al., 2017 [ | 3-PBA (nonspecific metabolite) | Girls ( | 9–15 | Urine/LC-MS | Positive association between increased concentration and delay in puberty progression tempo and age at menarche |
| Ye et al., 2017 [ | 3-PBA (nonspecific metabolite) | Boys ( | 9–16 | Urine/LC-MS | Positive association between increased concentration and acceleration in puberty progression tempo |
|
| |||||
| Sergeyev et al., 2017 [ | HCB, βHCH, p,p′-DDE | Boys ( | 8–9 | Serum/GC-MS | Delayed sexual maturation with HCB |
| Krstevska-Konstantinova et al., 2001 [ | p,p′-DDE | Girls and boys ( | 7.8–8.3 (mean age at diagnosis) | Serum/GC-MS/MS | Increased risk for idiopathic precocious puberty among immigrants from developing countries to Belgium |
| Croes et al., 2015 [ | HCB, p,p′-DDE | Boys and girls ( | 14–15 | Serum/GC-MS | Delayed sexual maturation in girls and accelerated in boys with HCB and |
| Bapayeva et al., 2016 [ | Lindane, dieldrin, endrin, DDT | Girls ( | 10–17 | Serum/GC-ECD | Delayed sexual maturation |
| Vasiliu et al., 2004 [ | DDE | Women ( | 20–50 | Maternal serum/GC-ECD | Acceleration of menarche |
| Ouyang et al., 2005 [ | DDT | Women ( | 20–36 | Serum/GC-ECD | Acceleration of menarche |
| DenHond et al., 2011 [ | HCB, p,p′-DDE | Boys ( | 14–15 | Serum/GC-ECD | Accelerated pubertal development in boys |
| Grandjean et al., 2012 [ | p,p′-DDE | Boys ( | 14 | Cord blood/GC-ECD | Negative association with pubertal development |
| Sayied et al., 2003 [ | Endosulfan | Boys ( | 10–19 | Serum/GC-ECD | Delayed pubertal development |
| Attfield et al., 2019 [ | DDE | Girls ( | 6–8 | Serum/GC-MS | Positive association between organochlorine pesticides concentration in the highest quartile and delayed menarche |
| Deng et al., 2012 [ | p,p′-DDE | Boys ( | ~3–9 | Serum/GC-ECD | Positive association between exposure and idiopathic precocious puberty |
|
| |||||
| Croes et al., 2015 [ | DMP, DMTP, DMDTP, DEDTP | Boys and girls ( | 14–15 | Urine/GC-MS | Delayed sexual maturation in boys with methyl metabolites and |
|
| |||||
| Namulanda et al., 2017 [ | Atrazine metabolites | Girls ( | 8–13 | Maternal urine during pregnancy (collected at 8th-17th week) /LC-MS/MS) | Positive association between maternal urine DACT concentrations and the risk for earlier menarche among prenatally exposed daughters |
|
| |||||
| Wohlfahrt-Veje et al., 2012 [ | Various pesticide categories | Boys ( | 6–11 | Indirect assessment (questionnaire) of occupational exposure of female greenhouse workers during their first trimester of pregnancy | Earlier thelarche in prenatally exposed daughters and |
3-PBA: 3-phenoxybenzoic acid; 3-phenoxybenzoic acid, LC: liquid chromatography; MS: mass spectrometry; HCB: hexachlorobenzene; βHCH: beta-hexachlorocyclohexane; DDE: dichlorodiphenyldichloroethylene; GC: gas chromatography; MS/MS: tandem mass spectrometry; DDT: dichlorodiphenyltrichloroethane; ECD: electron capture detector; USA: United States of America; DMP: dimethylphosphate; DMTP: dimethylthiophosphate; DMDTP: dimethyldithiophosphate; DEDTP: diethyldithiophosphate; DACT: diaminochlorotriazine.